Chemistry:MDM1EA
N-Methyl-1-(3,4-methylenedioxyphenyl)-1-ethanamine (MDM1EA), also known as α,N-dimethyl-3,4-methylenedioxybenzylamine (α,N-DMMDBA) or as α,N-dimethylpiperonylamine, is an entactogen-like drug of the benzylamine family related to MDMA.[1][2][3] It is the analogue of MDMA in which the side chain has been shortened by one carbon atom.[1][2][3]
The drug has been found to be a weak serotonin reuptake inhibitor and partially substituted for MDMA in rodent drug discrimination tests at the highest assessed doses.[1][2][4][3] The effects of α,N-DMMDBA in humans are unknown.[1]
It is not a controlled substance in the United States as of 2011.[1]
Homo-MDMA (HMDMA), an analogue of MDMA in which the side chain was extended by one carbon atom, has also been synthesized and studied.[2][3] It partially substituted for MDMA similarly to MDM1EA.[2][3]
See also
- ALPHA
- M-ALPHA
- Benzylpiperazine (BZP)
- Methylenedioxybenzylpiperazine (MDBZP)
- Homo-MDA
- Homo-MDMA
References
- ↑ 1.0 1.1 1.2 1.3 1.4 "#45. α,N-DMMDBA". The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds. 1. Berkeley, CA: Transform Press. 2011. pp. 80–81. ISBN 978-0-9630096-3-0. OCLC 709667010. https://archive.org/details/shulgin-index-vol-1/page/80/mode/1up.
- ↑ 2.0 2.1 2.2 2.3 2.4 (in de) Phenethylamine: von der Struktur zur Funktion. Nachtschatten-Science. Solothurn: Nachtschatten-Verlag. 2013. p. 594. ISBN 978-3-03788-700-4. OCLC 858805226. https://books.google.com/books?id=-Us1kgEACAAJ. Retrieved 29 January 2025.
- ↑ 3.0 3.1 3.2 3.3 3.4 "Behavioral and developmental effects of two 3,4-methylenedioxymethamphetamine (MDMA) derivatives". Drug and Alcohol Dependence 36 (3): 161–166. December 1994. doi:10.1016/0376-8716(94)90141-4. PMID 7889806.
- ↑ "Antagonism of 3,4-methylenedioxymethamphetamine-induced neurotoxicity in rat brain by 1-piperonylpiperazine". European Journal of Pharmacology 228 (2–3): 171–174. September 1992. doi:10.1016/0926-6917(92)90027-a. PMID 1280228.
External links
 |  |
